Jun 10, 2019 8:00am EDT Avalon GloboCare Announces Completion of Clinical-Grade Exosome Bio-Production Standardization with Launch of "ACTEX" Product Commercialization
May 21, 2019 9:00am EDT Avalon GloboCare Partners with MIT to Develop Innovative AI-Enhanced Protein Design Technology in Cellular Therapy
Apr 25, 2019 8:58am EDT Avalon GloboCare Announces $6 Million Registered Direct Offering with Institutional Investors
Apr 24, 2019 8:00am EDT Eminent M.I.T. Institute Professor, Robert S. Langer, Sc.D., Joins Avalon GloboCare's Scientific and Clinical Advisory Board
Apr 17, 2019 8:00am EDT Avalon GloboCare to Host The 3rd Annual International Scientific Forum on Exosome Research and Application (ISFERA) in Beijing on July 19, 2019
Apr 08, 2019 8:35am EDT Avalon GloboCare Appoints Finance Veteran Yue ''Charles'' Li to the Board of Directors
Mar 06, 2019 8:00am EST Avalon GloboCare to Present at the 31st Annual ROTH Conference on March 17-19, 2019
Feb 26, 2019 8:00am EST Avalon GloboCare Announces Filing of Provisional Patent Applications for AVA-101, a Novel Transposon-Based, Multi-Targeted CAR-T Therapy
Feb 11, 2019 8:30am EST Avalon GloboCare Announces Breakthrough in Identifying Human Angiogenic Exosomes/Extracellular Vesicles (EV) Derived from Endothelial Cells
Feb 04, 2019 8:15am EST Avalon GloboCare CEO David Jin, M.D., Ph.D. to Co-Chair the “Status of Cellular Therapy in the Asia Pacific Rim” Session at the Annual Meetings of the Transplantation and Cellular Therapy (TCT) -- ASBMT and CIBMTR Tandem Meeting 2019